论文部分内容阅读
目的:研究脂肪肝患者血脂、血糖和肝功酶学指标的变化。方法:选取我院收治的106例脂肪肝患者为实验组,和106例年龄、性别与实验组无明显差异的非脂肪肝患者为对照组进行研究。分别对两组人员抽血,检测血脂、血糖和肝功酶的指标。结果:实验组的脂肪肝患者血糖检测平均值、血脂平均值、肝功酶学指标普遍高于对照组非脂肪肝患者,实验组与对照组的差异具有统计学意义(P<0.05)。结论:实验组的脂肪肝患者与血糖、血脂、肝功酶学指标的变化具有相关性,早期对血脂、血糖和肝功酶学指标的检测有利于患者早期对疾病进行预防。
Objective: To study the changes of lipids, blood glucose and liver enzymes in patients with fatty liver. Methods: A total of 106 patients with fatty liver admitted to our hospital were selected as experimental group and 106 patients with non-steatohepatosis without significant difference in age and sex as control group. Respectively, two groups of blood, blood lipid, blood glucose and liver enzymes indicators. Results: The average blood glucose, serum lipid and liver enzymes in the fatty liver patients in the experimental group were generally higher than those in the non-fatty liver patients in the control group. The difference between the experimental group and the control group was statistically significant (P <0.05). Conclusion: The experimental group of fatty liver patients with blood glucose, blood lipids, hepatic enzymatic index changes are related to the early detection of serum lipids, blood glucose and liver enzymes is conducive to the prevention of disease in patients with early.